| Pregnancy |
1 |
1 |
| Uterus |
0 |
0.9 |
| Retroverted Uterus |
0 |
0.39 |
| Spontaneous Abortion |
0 |
0.99 |
| Genomic Medicine |
0 |
0.28 |
| Genetics |
0 |
0.26 |
| Adenomyosis |
0 |
0.23 |
| Antiphospholipid Syndrome |
0 |
0.17 |
| Gestational Age |
0 |
0.17 |
| Care and Maintenance of Vision |
0 |
0.16 |
| Cervix |
0 |
0.14 |
| Premature Birth |
0 |
0.14 |
| Thromboembolism |
0 |
0.14 |
| Ultrasonography |
0 |
0.14 |
| Birth |
0 |
0.12 |
| Fundus |
0 |
0.12 |
| Congenital Anomaly |
0 |
0.1 |
| Bladder |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Contraception |
0 |
0.09 |
| Deep Venous Thrombosis |
0 |
0.09 |
| Microarray Technologies |
0 |
0.09 |
| Tissue |
0 |
0.09 |
| First Trimester Pregnancy Loss |
0 |
0.08 |
| Aspirin |
0 |
0.06 |
| Fetal Growth Restriction |
0 |
0.06 |
| Fibroma |
0 |
0.06 |
| First Trimester Pregnancy |
0 |
0.06 |
| Maryland |
0 |
0.06 |
| Maternal-Fetal Medicine |
0 |
0.06 |
| Pelvis |
0 |
0.06 |
| Unfractionated Heparin |
0 |
0.06 |